Učitavanje...
Isotype-specific inhibition of the phosphatidylinositol-3-kinase pathway in hematologic malignancies
In the last decade, the advent of biological targeted therapies has revolutionized the management of several types of cancer, especially in the realm of hematologic malignancies. One of these pathways, and the center of this review, is the phosphatidylinositol-3-kinase (PI3K) pathway. The PI3K pathw...
Spremljeno u:
| Glavni autori: | , , , |
|---|---|
| Format: | Artigo |
| Jezik: | Inglês |
| Izdano: |
Dove Medical Press
2014
|
| Teme: | |
| Online pristup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3937185/ https://ncbi.nlm.nih.gov/pubmed/24591840 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/OTT.S34641 |
| Oznake: |
Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!
|